The insulin receptor substrate (IRS) family of proteins mediate a variety o
f intracellular signaling events by serving as signaling platforms downstre
am of several receptor tyrosine kinases including the insulin and insulin-l
ike growth factor-1 (IGF-1) receptors. Recently, several new members of thi
s family have been identified including IRS-3, IRS-4, and growth factor rec
eptor-binding protein a-associated binder-1 (Gab-l). 3T3 cell lines derived
from IRS-l-deficient embryos exhibit a 70-80% reduction in IGF-l-stimulate
d S-phase entry and a parallel decrease in the induction of the immediate-e
arly genes c-fos and egr-1 but unaltered activation of the mitogen-activate
d protein kinases extracellular signal-regulated kinase-l and extracellular
signal-regulated kinase-2. Reconstitution of IRS-1 expression in IRS-1-def
icient fibroblasts by retroviral mediated gene transduction is capable of r
estoring these defects. Overexpression of Gab-l in IRS-l-deficient fibrobla
sts also results in the restoration of egr-1 induction to levels similar to
those achieved by IRS-1 reconstitution and markedly increases IGF-l-stimul
ated S-phase progression. Gab-l is capable of regulating these biological e
nd points despite the absence of IGF-1 stimulated tyrosine phosphorylation.
These data provide evidence that Gab-l may serve as a unique signaling int
ermediate in insulin/IGF-1 signaling for induction of early gene expression
and stimulation of mitogenesis without direct tyrosine phosphorylation.